Kiniksa Pharmaceuticals International Plc (KNSA)
95.76
+0.74
(+0.78%)
USD |
NASDAQ |
Nov 11, 16:00
95.83
+0.07
(+0.07%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Market Cap : 7.516B for Nov. 11, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 11, 2026 | 7.516B |
| November 10, 2026 | 7.458B |
| November 09, 2026 | 7.751B |
| November 06, 2026 | 7.366B |
| November 05, 2026 | 6.933B |
| November 04, 2026 | 7.544B |
| November 03, 2026 | 7.322B |
| November 02, 2026 | 7.126B |
| October 30, 2026 | 7.239B |
| October 29, 2026 | 7.657B |
| October 28, 2026 | 7.470B |
| October 27, 2026 | 7.001B |
| October 26, 2026 | 5.728B |
| October 23, 2026 | 6.022B |
| October 22, 2026 | 6.300B |
| October 21, 2026 | 6.215B |
| October 20, 2026 | 6.486B |
| October 19, 2026 | 6.198B |
| October 16, 2026 | 6.128B |
| October 15, 2026 | 6.234B |
| October 14, 2026 | 6.148B |
| October 13, 2026 | 6.124B |
| October 12, 2026 | 6.179B |
| October 09, 2026 | 6.221B |
| October 08, 2026 | 6.141B |
| Date | Value |
|---|---|
| October 07, 2026 | 6.079B |
| October 06, 2026 | 6.011B |
| October 05, 2026 | 5.951B |
| October 02, 2026 | 5.910B |
| October 01, 2026 | 5.866B |
| September 30, 2026 | 5.818B |
| September 29, 2026 | 5.905B |
| September 28, 2026 | 5.934B |
| September 25, 2026 | 5.855B |
| September 24, 2026 | 5.875B |
| September 23, 2026 | 5.933B |
| September 22, 2026 | 6.082B |
| September 21, 2026 | 6.093B |
| September 18, 2026 | 6.023B |
| September 17, 2026 | 6.186B |
| September 16, 2026 | 6.053B |
| September 15, 2026 | 5.860B |
| September 14, 2026 | 5.972B |
| September 11, 2026 | 5.948B |
| September 10, 2026 | 5.964B |
| September 09, 2026 | 6.123B |
| September 08, 2026 | 6.011B |
| September 04, 2026 | 6.075B |
| September 03, 2026 | 6.275B |
| September 02, 2026 | 6.230B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Autolus Therapeutics Plc | 328.93M |
| Scancell Holdings Plc | 119.34M |
| OptiBiotix Health Plc | 11.36M |
| Adaptimmune Therapeutics Plc | 7.952M |
| Bicycle Therapeutics Plc | 186.55M |
Market Cap Related Metrics
| PE Ratio | 73.06 |
| PS Ratio | 8.410 |
| PEG Ratio | 0.3798 |
| Price to Book Value | 10.58 |
| Price to Free Cash Flow | 40.34 |
| Price | 95.76 |
| Earnings Yield | 1.37% |
| PEGY Ratio | 0.3798 |
| Operating PE Ratio | 60.98 |
| Normalized PE Ratio | 73.06 |